JAKARTA (Yosefardi) – State pharmaceutical company PT Kalbe Farma Tbk (KLBF) is keen to acquire shares of PT Phapros Tbk, unit of PT Rajawali Nusantara Indonesia (RNI), through the initial public offering (IPO).
Phapros plans to launch its IPO by early next year. KLBF allocates Rp500 billion for acquisition purpose in a year.
This year, the company focuses to acquire healty food company, now in talks with 5-10 companies.
KLBF revised its revenues growth target this year to 11-13%, from initial target of 14-16%. Net profit target is also revised to 11-13% from initial 15-17%.
The company booked revenues of Rp8.3 trillion in first half of 2014, grew by 12.9%, and booked profit of Rp992.9 billion, a 7.7% rise.